0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Monoclonal Antibody Therapy of Human Cancer (Hardcover, 1985 ed.) Loot Price: R2,745
Discovery Miles 27 450
Monoclonal Antibody Therapy of Human Cancer (Hardcover, 1985 ed.): Kenneth A. Foon, Alton C. Morgan

Monoclonal Antibody Therapy of Human Cancer (Hardcover, 1985 ed.)

Kenneth A. Foon, Alton C. Morgan

Series: Developments in Oncology, 38

 (sign in to rate)
Loot Price R2,745 Discovery Miles 27 450 | Repayment Terms: R257 pm x 12*

Bookmark and Share

Expected to ship within 10 - 17 working days

KENNETH A. FOON and ALTON C. MORGAN, JR. Passive immunotherapy using heteroantisera for the treatment of cancer in animals and humans has been studied for over 50 years. Attempts have been made to treat animal tumors with sera from immunized syngeneic, allogeneic, or xenogeneic animals. A number of studies of passive immunotherapy using heterologous antisera in humans have also been performed. These studies have generally been attempted in patients with large tumor burdens, and as would be expected, results have been transient at best. A wide variety of solid tumors as well as leukemias and lym- phomas have been treated with antisera raised in sheep, horses, rabbits, and goats. Problems such as anaphylaxis, serum sick- ness, and severe cytopenias have been encountered with these antisera. There are a number of potential mechanisms by which unconju- gated antibodies might be cytotoxic to tumor cells. Antibodies bound to the cell surface membrane of tumor cells may lead to cell lysis by complement-dependent or antibody-dependent cellu- lar cytotoxicity. Circulating tumor cells bound by antibody may be more susceptible to phagocytosis by the reticuloendothelial system. Antibody bound to the cell surface membrane of tumor cells may enhance immunogenicity of the tumor cell leading to activation of the host's immune system.

General

Imprint: Kluwer Academic Publishers
Country of origin: United States
Series: Developments in Oncology, 38
Release date: September 1985
First published: 1985
Editors: Kenneth A. Foon • Alton C. Morgan
Dimensions: 234 x 156 x 11mm (L x W x T)
Format: Hardcover
Pages: 162
Edition: 1985 ed.
ISBN-13: 978-0-89838-754-4
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
Promotions
LSN: 0-89838-754-X
Barcode: 9780898387544

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Biomarkers in Cancer Detection and…
Ranbir Chander Sobti, Masatoshi Watanabe, … Paperback R3,268 Discovery Miles 32 680
Targeted Nanomedicine for Breast Cancer…
Shivani Rai Paliwal, Rishi Paliwal Paperback R4,491 Discovery Miles 44 910
Encyclopedia of Infection and Immunity
Nima Rezaei Hardcover R58,452 Discovery Miles 584 520
Bone Cancer - Bone Sarcomas and Bone…
Dominique Heymann Hardcover R5,123 Discovery Miles 51 230
Immunotherapy in Resistant Cancer: From…
Jorge Morales Montor, Mariana Segovia Hardcover R3,506 Discovery Miles 35 060
Sphingolipids in Cancer, Volume 140
Charles E. Chalfant, Paul B. Fisher Hardcover R3,743 Discovery Miles 37 430
Lung Cancer, An Issue of…
Roy S. Herbst, Daniel Morgensztern Hardcover R2,125 Discovery Miles 21 250
Adjunctive Rehabilitation Approaches to…
Andrea L. Cheville Hardcover R2,127 Discovery Miles 21 270
Pediatric Brain Tumors Update, An Issue…
Lara Brandao Hardcover R2,143 Discovery Miles 21 430
Geriatric Oncology, An Issue of Clinics…
Harvey J. Cohen, Arati V Rao Hardcover R1,693 Discovery Miles 16 930
Neuroendocrine Tumors, An Issue of…
Jennifer Chan, Matthew Kulke Hardcover R1,696 Discovery Miles 16 960
Testicular Cancer, An Issue of Urologic…
Daniel W. Lin Hardcover R1,697 Discovery Miles 16 970

See more

Partners